dimethylphenylpiperazinium iodide has been researched along with Angiogenesis, Pathologic in 1 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, YQ | 1 |
| Li, Y | 1 |
| Wang, XY | 1 |
| He, XD | 1 |
| Jun, L | 1 |
| Chuai, M | 1 |
| Lee, KK | 1 |
| Wang, J | 1 |
| Wang, LJ | 1 |
| Yang, X | 1 |
1 other study available for dimethylphenylpiperazinium iodide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Dimethyl phenyl piperazine iodide (DMPP) induces glioma regression by inhibiting angiogenesis.
Topics: Animals; Cell Proliferation; Cell Survival; Chick Embryo; Dimethylphenylpiperazinium Iodide; Glioma; | 2014 |